{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T02:04:45Z","timestamp":1771553085110,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Breast J"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1111\/tbj.14241","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T01:08:45Z","timestamp":1621559325000},"page":"631-637","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["HER\u20102\/<i>neu<\/i>\u2010positive breast cancer neoadjuvant chemotherapy response after implementation of 2018 ASCO\/CAP focused update"],"prefix":"10.1155","volume":"27","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[{"name":"Medical College of Wisconsin Milwaukee WI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya Ruth","family":"Asirvatham","sequence":"additional","affiliation":[{"name":"University of Florida Gainsville FL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlin","family":"Ma","sequence":"additional","affiliation":[{"name":"University of Virginia Charlottesville VA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-6538","authenticated-orcid":false,"given":"Emily S.","family":"Reisenbichler","sequence":"additional","affiliation":[{"name":"Yale School of Medicine New Haven CT USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7777-6670","authenticated-orcid":false,"given":"Julie M.","family":"Jorns","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin Milwaukee WI USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,5,20]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1586\/era.10.226"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.5858\/2010-0454-RAR.1"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.4155\/cli.14.57"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-6053-6"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.2779"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234191"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8738"},{"key":"e_1_2_7_10_1","unstructured":"U.S Food and Drug Administration Guidance for Industry: Pathological complete response in neoadjuvant treatment of high\u2010risk early\u2010stage breast cancer: use as an endpoint to support accelerated approval.http:\/\/www.fda.gov\/downloads\/DrU.SGuidanceComplianceRegulatoryInformation\/Guidances\/UCM305501.pdf. Accessed Nov 2020"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.10.6823"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3"},{"key":"e_1_2_7_13_1","unstructured":"The University of Texas MD Anderson Cancer Center. Residual cancer burden calculator.http:\/\/www3.mdanderson.org\/app\/medcalc\/index.cfm?pagename=jsconvert3. 2020 Accessed Nov 2020"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-017-5863-x"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70336-9"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.1010"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-019-05295-9"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPIRL4GUVGK3YX"},{"key":"e_1_2_7_19_1","first-page":"EC01","article-title":"HER2\/neu testing in 432 consecutive breast cancer cases using FISH and IHC\u2010A comparative study","volume":"11","author":"Eswarachary V","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"e_1_2_7_20_1","first-page":"43","article-title":"Is There any Concordance between of IHC with FISH in HER2\u2010Positive Breast Cancer Patients?","volume":"11","author":"Payandeh M","year":"2017","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-4755-5"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12407"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/cge.13900"},{"key":"e_1_2_7_24_1","doi-asserted-by":"crossref","unstructured":"PiccartM ProcterM FumagalliD et al.:Interim overall survival analysis of APHINITY (BIG 4\u201011): A randomized multicenter double\u2010blind placebo\u2010controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab vs chemotherapy plus trastuzumab plus placebo as adjuvant therapy in patients with operable HER2\u2010positive early breast cancer. 2019 San Antonio Breast Cancer Symposium; December 11 2019; San Antonio TX; Abstract GS1\u201004.","DOI":"10.1158\/1538-7445.SABCS19-GS1-04"}],"container-title":["The Breast Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tbj.14241","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tbj.14241","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tbj.14241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T05:19:06Z","timestamp":1672204746000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tbj.14241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,20]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1111\/tbj.14241"],"URL":"https:\/\/doi.org\/10.1111\/tbj.14241","archive":["Portico"],"relation":{},"ISSN":["1075-122X","1524-4741"],"issn-type":[{"value":"1075-122X","type":"print"},{"value":"1524-4741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,20]]},"assertion":[{"value":"2021-03-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}